Anzeige
Erschienen in:
01.08.2011 | Original Article
Implanon: Subdermal Single Rod Contraceptive Implant
Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2011
Einloggen, um Zugang zu erhaltenAbstract
Objectives
Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.
Methods
Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy.
Results
200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months.
Conclusions
Implanon is safe, effective, well accepted method of contraception.